LifeStance Health Price to Free Cash Flow Ratio 2020-2024 | LFST

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

LifeStance Health price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

LifeStance Health price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$20.9B
Quest Diagnostics (DGX)	$16.9B
DaVita (DVA)	$13.6B
Encompass Health (EHC)	$9.5B
Chemed (CHE)	$8.3B
Elanco Animal Health (ELAN)	$5.9B
Option Care Health (OPCH)	$5B
RadNet (RDNT)	$4.4B
Amedisys (AMED)	$3B
Addus HomeCare (ADUS)	$2.4B
Astrana Health (ASTH)	$2B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$943M
Aveanna Healthcare Holdings (AVAH)	$899M
Atai Life Sciences (ATAI)	$245M
Bioqual (BIOQ)	$58M
Daxor (DXR)	$41M
Ontrak (OTRK)	$7M
MEDIROM Healthcare Technologies (MRM)	$5M
IMAC Holdings (BACK)	$3M
Psychemedics (PMD)	$0M